Free Trial

FibroBiologics (FBLG) SEC Filings & 10K Form

FibroBiologics logo
$1.02 -0.10 (-8.93%)
Closing price 04:00 PM Eastern
Extended Trading
$1.00 -0.02 (-1.67%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent FibroBiologics SEC Filings

DateFilerForm TypeView
04/23/2025
5:01 AM
FibroBiologics (Filer)
Form DEF 14A
04/23/2025
5:05 AM
FibroBiologics (Filer)
Form DEFA14A
04/23/2025
5:10 AM
FibroBiologics (Filer)
Form ARS
03/31/2025
3:04 PM
FibroBiologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/10/2025
11:15 PM
FibroBiologics (Filer)
Form EFFECT
02/07/2025
4:24 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
8:19 AM
FibroBiologics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/30/2025
11:43 AM
BlackRock, Inc. (Filed by)
FibroBiologics (Subject)
Form SCHEDULE 13G/A
01/29/2025
3:43 PM
BlackRock, Inc. (Filed by)
FibroBiologics (Subject)
Form SCHEDULE 13G
01/21/2025
11:15 PM
FibroBiologics (Filer)
Form EFFECT
01/14/2025
11:15 PM
FibroBiologics (Filer)
Form EFFECT
01/14/2025
3:34 PM
FibroBiologics (Filer)
Form 424B4
01/10/2025
4:22 PM
FibroBiologics (Filer)
Form S-1/A
12/31/2024
3:20 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:18 PM
FibroBiologics (Issuer)
GARCIA RUBEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:20 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:21 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
7:29 AM
FibroBiologics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/23/2024
7:00 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:15 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:33 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
6:47 PM
Cilento Richard C. Jr. (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:51 PM
Coen Stacy Ann (Reporting)
FibroBiologics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:53 PM
FibroBiologics (Issuer)
Hoffman Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:54 PM
FibroBiologics (Issuer)
Link Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
6:55 PM
FibroBiologics (Issuer)
Niklas Victoria Ninon Olivia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:01 PM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
08/12/2024
8:57 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 3/A
08/12/2024
8:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 3/A
08/12/2024
8:58 PM
FibroBiologics (Issuer)
Khoja Hamid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:58 PM
FibroBiologics (Issuer)
O'HEERON PETE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:21 PM
FibroBiologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2024
10:23 AM
FibroBiologics (Filer)
Form DEF 14A
07/08/2024
10:25 AM
FibroBiologics (Filer)
Form DEFA14A
07/08/2024
10:27 AM
FibroBiologics (Filer)
Form ARS
06/27/2024
4:16 PM
FibroBiologics (Filer)
Form PRE 14A
06/27/2024
6:22 AM
FibroBiologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
What President Trump’s Executive Order 14154 means for your money (Ad)

Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard.

But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi
06/26/2024
5:11 AM
FibroBiologics (Filer)
Form 424B4
06/25/2024
11:15 PM
FibroBiologics (Filer)
Form EFFECT
06/06/2024
9:58 AM
FibroBiologics (Filer)
Form RW
06/04/2024
1:36 PM
FibroBiologics (Filer)
Form S-1/A
05/14/2024
3:05 PM
FibroBiologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FBLG) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners